Market Research Industry Reports

Generics Global Industry Almanac 2017-2021

  • DESCRIPTION
  • TABLE OF CONTENTS
  • RELATED REPORTS
  • SAMPLE REQUEST
  • REVIEWS
Generics Global Industry Almanac 2017-2021

Summary

Global Generics industry profile provides top-line qualitative and quantitative summary information including: market size (value and volume 2012-16, and forecast to 2021). The profile also contains descriptions of the leading players including key financial metrics and analysis of competitive pressures within the market.

Synopsis

Essential resource for top-line data and analysis covering the global generics market. Includes market size data, textual and graphical analysis of market growth trends and leading companies.

Key Highlights

- For the purposes of this profile, a generic is defined as a copy of an ethical (prescription) drug formerly protected by patents that have now expired. Both unbranded generics and all branded generics are included. However, off-patent drugs that continue to be offered by the original manufacturer under the original name, and which form part of the generic-eligible market, are not included. The market value is evaluated at ex-factory prices. Market volume is quantified here as the percentage of the total ethical pharmaceutical market volume in a country or region which is accounted for by generic drugs. It is therefore a generics penetration rate measure, not an absolute measure of market volume.Regional volumes are calculated as weighted averages of countries which make up the region in question where volume data exists.Please note that any volumes of "1" (one) or 100% are due to rounding as MarketLine does not believe that generics will ever fully represent 100% of the medicinal market in any country or region.All currency conversions were calculated at constant average annual 2016 exchange rates.
- The global generics market had total revenues of $311.1bn in 2016, representing a compound annual growth rate (CAGR) of 9.5% between 2012 and 2016.
- Market consumption volume increased with a CAGR of 2.2% between 2012 and 2016, to reach a total of 82.1% of total pharma volume in 2016.
- Strong growth will continue in the emerging markets but worldwide there will be a deceleration.

Scope

- Save time carrying out entry-level research by identifying the size, growth, and leading players in the global generics market
- Use the Five Forces analysis to determine the competitive intensity and therefore attractiveness of the global generics market
- Leading company profiles reveal details of key generics market players global operations and financial performance
- Add weight to presentations and pitches by understanding the future growth prospects of the global generics market with five year forecasts by both value and volume

Reasons to buy

- What was the size of the global generics market by value in 2016?
- What will be the size of the global generics market in 2021?
- What factors are affecting the strength of competition in the global generics market?
- How has the market performed over the last five years?
- How large is the global generics market in relation to its regional counterparts?

EXECUTIVE SUMMARY 2
Market value 2
Market value forecast 2
Market volume 2
Market volume forecast 2
Geography segmentation 2
Introduction 32
What is this report about? 32
Who is the target reader? 32
How to use this report 32
Definitions 32
Global Generics 33
Market Overview 33
Market Data 34
Market Segmentation 36
Market outlook 37
Five forces analysis 39
Generics in Asia-Pacific 45
Market Overview 45
Market Data 46
Market Segmentation 48
Market outlook 49
Five forces analysis 51
Generics in Europe 57
Market Overview 57
Market Data 58
Market Segmentation 60
Market outlook 61
Five forces analysis 63
Generics in France 69
Market Overview 69
Market Data 70
Market Segmentation 72
Market outlook 73
Five forces analysis 75
Macroeconomic indicators 81
Generics in Germany 83
Market Overview 83
Market Data 84
Market Segmentation 86
Market outlook 87
Five forces analysis 89
Macroeconomic indicators 95
Generics in Australia 97
Market Overview 97
Market Data 98
Market Segmentation 100
Market outlook 101
Five forces analysis 103
Macroeconomic indicators 109
Generics in Brazil 111
Market Overview 111
Market Data 112
Market Segmentation 114
Market outlook 115
Five forces analysis 117
Macroeconomic indicators 123
Generics in Canada 125
Market Overview 125
Market Data 126
Market Segmentation 128
Market outlook 129
Five forces analysis 131
Macroeconomic indicators 137
Generics in China 139
Market Overview 139
Market Data 140
Market Segmentation 142
Market outlook 143
Five forces analysis 145
Macroeconomic indicators 152
Generics in India 154
Market Overview 154
Market Data 155
Market Segmentation 157
Market outlook 158
Five forces analysis 160
Macroeconomic indicators 166
Generics in Indonesia 168
Market Overview 168
Market Data 169
Market Segmentation 171
Market outlook 172
Five forces analysis 174
Macroeconomic indicators 180
Generics in Italy 182
Market Overview 182
Market Data 183
Market Segmentation 185
Market outlook 186
Five forces analysis 188
Macroeconomic indicators 194
Generics in Japan 196
Market Overview 196
Market Data 197
Market Segmentation 199
Market outlook 200
Five forces analysis 202
Macroeconomic indicators 208
Generics in Mexico 210
Market Overview 210
Market Data 211
Market Segmentation 213
Market outlook 214
Five forces analysis 216
Macroeconomic indicators 222
Generics in The Netherlands 224
Market Overview 224
Market Data 225
Market Segmentation 227
Market outlook 228
Five forces analysis 230
Macroeconomic indicators 236
Generics in North America 238
Market Overview 238
Market Data 239
Market Segmentation 241
Market outlook 242
Five forces analysis 244
Generics in Russia 251
Market Overview 251
Market Data 252
Market Segmentation 254
Market outlook 255
Five forces analysis 257
Macroeconomic indicators 263
Generics in Scandinavia 265
Market Overview 265
Market Data 266
Market Segmentation 268
Market outlook 269
Five forces analysis 271
Generics in Singapore 277
Market Overview 277
Market Data 278
Market Segmentation 280
Market outlook 281
Five forces analysis 283
Macroeconomic indicators 289
Generics in South Africa 291
Market Overview 291
Market Data 292
Market Segmentation 294
Market outlook 295
Five forces analysis 297
Macroeconomic indicators 303
Generics in South Korea 305
Market Overview 305
Market Data 306
Market Segmentation 308
Market outlook 309
Five forces analysis 311
Macroeconomic indicators 317
Generics in Spain 319
Market Overview 319
Market Data 320
Market Segmentation 322
Market outlook 323
Five forces analysis 325
Macroeconomic indicators 331
Generics in Turkey 333
Market Overview 333
Market Data 334
Market Segmentation 336
Market outlook 337
Five forces analysis 339
Macroeconomic indicators 345
Generics in The United Kingdom 347
Market Overview 347
Market Data 348
Market Segmentation 350
Market outlook 351
Five forces analysis 353
Macroeconomic indicators 359
Generics in The United States 361
Market Overview 361
Market Data 362
Market Segmentation 364
Market outlook 365
Five forces analysis 367
Macroeconomic indicators 373
Company Profiles 375
Leading Companies 375
Appendix 447
Methodology 447
About MarketLine 448

List Of Tables

List of Tables
Table 1: Global generics market value: $ billion, 2012-16
Table 2: Global generics market volume: % of total pharma volume, 2012-16
Table 3: Global generics market geography segmentation: $ billion, 2016
Table 4: Global generics market value forecast: $ billion, 2016-21
Table 5: Global generics market volume forecast: % of total pharma volume, 2016-21
Table 6: Asia-Pacific generics market value: $ billion, 2012-16
Table 7: Asia-Pacific generics market volume: % of total pharma volume, 2012-16
Table 8: Asia-Pacific generics market geography segmentation: $ billion, 2016
Table 9: Asia-Pacific generics market value forecast: $ billion, 2016-21
Table 10: Asia-Pacific generics market volume forecast: % of total pharma volume, 2016-21
Table 11: Europe generics market value: $ billion, 2012-16
Table 12: Europe generics market volume: % of total pharma volume, 2012-16
Table 13: Europe generics market geography segmentation: $ billion, 2016
Table 14: Europe generics market value forecast: $ billion, 2016-21
Table 15: Europe generics market volume forecast: % of total pharma volume, 2016-21
Table 16: France generics market value: $ million, 2012-16
Table 17: France generics market volume: % of total pharma volume, 2012-16
Table 18: France generics market geography segmentation: $ million, 2016
Table 19: France generics market value forecast: $ million, 2016-21
Table 20: France generics market volume forecast: % of total pharma volume, 2016-21
Table 21: France size of population (million), 2012-16
Table 22: France gdp (constant 2005 prices, $ billion), 2012-16
Table 23: France gdp (current prices, $ billion), 2012-16
Table 24: France inflation, 2012-16
Table 25: France consumer price index (absolute), 2012-16
Table 26: France exchange rate, 2012-16
Table 27: Germany generics market value: $ million, 2012-16
Table 28: Germany generics market volume: % of total pharma volume, 2012-16
Table 29: Germany generics market geography segmentation: $ million, 2016
Table 30: Germany generics market value forecast: $ million, 2016-21
Table 31: Germany generics market volume forecast: % of total pharma volume, 2016-21
Table 32: Germany size of population (million), 2012-16
Table 33: Germany gdp (constant 2005 prices, $ billion), 2012-16
Table 34: Germany gdp (current prices, $ billion), 2012-16
Table 35: Germany inflation, 2012-16
Table 36: Germany consumer price index (absolute), 2012-16
Table 37: Germany exchange rate, 2012-16
Table 38: Australia generics market value: $ million, 2012-16
Table 39: Australia generics market volume: % of total pharma volume, 2012-16
Table 40: Australia generics market geography segmentation: $ million, 2016
Table 41: Australia generics market value forecast: $ million, 2016-21
Table 42: Australia generics market volume forecast: % of total pharma volume, 2016-21
Table 43: Australia size of population (million), 2012-16
Table 44: Australia gdp (constant 2005 prices, $ billion), 2012-16
Table 45: Australia gdp (current prices, $ billion), 2012-16
Table 46: Australia inflation, 2012-16
Table 47: Australia consumer price index (absolute), 2012-16
Table 48: Australia exchange rate, 2012-16
Table 49: Brazil generics market value: $ million, 2012-16
Table 50: Brazil generics market volume: % of total pharma volume, 2012-16
Table 51: Brazil generics market geography segmentation: $ million, 2016
Table 52: Brazil generics market value forecast: $ million, 2016-21
Table 53: Brazil generics market volume forecast: % of total pharma volume, 2016-21
Table 54: Brazil size of population (million), 2012-16
Table 55: Brazil gdp (constant 2005 prices, $ billion), 2012-16
Table 56: Brazil gdp (current prices, $ billion), 2012-16
Table 57: Brazil inflation, 2012-16
Table 58: Brazil consumer price index (absolute), 2012-16
Table 59: Brazil exchange rate, 2012-16
Table 60: Canada generics market value: $ million, 2012-16
Table 61: Canada generics market volume: % of total pharma volume, 2012-16
Table 62: Canada generics market geography segmentation: $ million, 2016
Table 63: Canada generics market value forecast: $ million, 2016-21
Table 64: Canada generics market volume forecast: % of total pharma volume, 2016-21
Table 65: Canada size of population (million), 2012-16
Table 66: Canada gdp (constant 2005 prices, $ billion), 2012-16
Table 67: Canada gdp (current prices, $ billion), 2012-16
Table 68: Canada inflation, 2012-16
Table 69: Canada consumer price index (absolute), 2012-16
Table 70: Canada exchange rate, 2012-16
Table 71: China generics market value: $ billion, 2012-16
Table 72: China generics market volume: % of total pharma volume, 2012-16
Table 73: China generics market geography segmentation: $ billion, 2016
Table 74: China generics market value forecast: $ billion, 2016-21
Table 75: China generics market volume forecast: % of total pharma volume, 2016-21

List Of Figures

List of Figures
Figure 1: Global generics market value: $ billion, 2012-16
Figure 2: Global generics market volume: % of total pharma volume, 2012-16
Figure 3: Global generics market geography segmentation: % share, by value, 2016
Figure 4: Global generics market value forecast: $ billion, 2016-21
Figure 5: Global generics market volume forecast: % of total pharma volume, 2016-21
Figure 6: Forces driving competition in the global generics market, 2016
Figure 7: Drivers of buyer power in the global generics market, 2016
Figure 8: Drivers of supplier power in the global generics market, 2016
Figure 9: Factors influencing the likelihood of new entrants in the global generics market, 2016
Figure 10: Factors influencing the threat of substitutes in the global generics market, 2016
Figure 11: Drivers of degree of rivalry in the global generics market, 2016
Figure 12: Asia-Pacific generics market value: $ billion, 2012-16
Figure 13: Asia-Pacific generics market volume: % of total pharma volume, 2012-16
Figure 14: Asia-Pacific generics market geography segmentation: % share, by value, 2016
Figure 15: Asia-Pacific generics market value forecast: $ billion, 2016-21
Figure 16: Asia-Pacific generics market volume forecast: % of total pharma volume, 2016-21
Figure 17: Forces driving competition in the generics market in Asia-Pacific, 2016
Figure 18: Drivers of buyer power in the generics market in Asia-Pacific, 2016
Figure 19: Drivers of supplier power in the generics market in Asia-Pacific, 2016
Figure 20: Factors influencing the likelihood of new entrants in the generics market in Asia-Pacific, 2016
Figure 21: Factors influencing the threat of substitutes in the generics market in Asia-Pacific, 2016
Figure 22: Drivers of degree of rivalry in the generics market in Asia-Pacific, 2016
Figure 23: Europe generics market value: $ billion, 2012-16
Figure 24: Europe generics market volume: % of total pharma volume, 2012-16
Figure 25: Europe generics market geography segmentation: % share, by value, 2016
Figure 26: Europe generics market value forecast: $ billion, 2016-21
Figure 27: Europe generics market volume forecast: % of total pharma volume, 2016-21
Figure 28: Forces driving competition in the generics market in Europe, 2016
Figure 29: Drivers of buyer power in the generics market in Europe, 2016
Figure 30: Drivers of supplier power in the generics market in Europe, 2016
Figure 31: Factors influencing the likelihood of new entrants in the generics market in Europe, 2016
Figure 32: Factors influencing the threat of substitutes in the generics market in Europe, 2016
Figure 33: Drivers of degree of rivalry in the generics market in Europe, 2016
Figure 34: France generics market value: $ million, 2012-16
Figure 35: France generics market volume: % of total pharma volume, 2012-16
Figure 36: France generics market geography segmentation: % share, by value, 2016
Figure 37: France generics market value forecast: $ million, 2016-21
Figure 38: France generics market volume forecast: % of total pharma volume, 2016-21
Figure 39: Forces driving competition in the generics market in France, 2016
Figure 40: Drivers of buyer power in the generics market in France, 2016
Figure 41: Drivers of supplier power in the generics market in France, 2016
Figure 42: Factors influencing the likelihood of new entrants in the generics market in France, 2016
Figure 43: Factors influencing the threat of substitutes in the generics market in France, 2016
Figure 44: Drivers of degree of rivalry in the generics market in France, 2016
Figure 45: Germany generics market value: $ million, 2012-16
Figure 46: Germany generics market volume: % of total pharma volume, 2012-16
Figure 47: Germany generics market geography segmentation: % share, by value, 2016
Figure 48: Germany generics market value forecast: $ million, 2016-21
Figure 49: Germany generics market volume forecast: % of total pharma volume, 2016-21
Figure 50: Forces driving competition in the generics market in Germany, 2016
Figure 51: Drivers of buyer power in the generics market in Germany, 2016
Figure 52: Drivers of supplier power in the generics market in Germany, 2016
Figure 53: Factors influencing the likelihood of new entrants in the generics market in Germany, 2016
Figure 54: Factors influencing the threat of substitutes in the generics market in Germany, 2016
Figure 55: Drivers of degree of rivalry in the generics market in Germany, 2016
Figure 56: Australia generics market value: $ million, 2012-16
Figure 57: Australia generics market volume: % of total pharma volume, 2012-16
Figure 58: Australia generics market geography segmentation: % share, by value, 2016
Figure 59: Australia generics market value forecast: $ million, 2016-21
Figure 60: Australia generics market volume forecast: % of total pharma volume, 2016-21
Figure 61: Forces driving competition in the generics market in Australia, 2016
Figure 62: Drivers of buyer power in the generics market in Australia, 2016
Figure 63: Drivers of supplier power in the generics market in Australia, 2016
Figure 64: Factors influencing the likelihood of new entrants in the generics market in Australia, 2016
Figure 65: Factors influencing the threat of substitutes in the generics market in Australia, 2016
Figure 66: Drivers of degree of rivalry in the generics market in Australia, 2016
Figure 67: Brazil generics market value: $ million, 2012-16
Figure 68: Brazil generics market volume: % of total pharma volume, 2012-16
Figure 69: Brazil generics market geography segmentation: % share, by value, 2016
Figure 70: Brazil generics market value forecast: $ million, 2016-21
Figure 71: Brazil generics market volume forecast: % of total pharma volume, 2016-21
Figure 72: Forces driving competition in the generics market in Brazil, 2016
Figure 73: Drivers of buyer power in the generics market in Brazil, 2016
Figure 74: Drivers of supplier power in the generics market in Brazil, 2016
Figure 75: Factors influencing the likelihood of new entrants in the generics market in Brazil, 2016

Global Generics Industry Profile & Value Chain Analysis

Global Generics Industry Profile & Value Chain AnalysisGlobal Generics industry profile provides top-line qualitative and quantitative information including: market size (value and volume 2012-16, and forecast to 2021). The

USD 495View Report

Generics Global Industry Guide 2017-2021

Generics Global Industry Guide 2017-2021Global Generics industry profile provides top-line qualitative and quantitative summary information including: market size (value and volume 2012-16, and forecast to 2021). The profile also contains

USD 1495View Report

Hybrid and Electric Cars Global Industry Guide 2013-2022

Hybrid and Electric Cars Global Industry Guide 2013-2022Global Hybrid and Electric Cars industry profile provides top-line qualitative and quantitative information including: Market size (value and volume 2013-17, and forecast

USD 1495View Report

Paints and Coatings Global Industry Guide 2013-2022

Paints & Coatings Global Industry Guide 2013-2022- Industry Analysis, Size, Share, Growth, Trends, and Forecast

USD 1495View Report

Your are not allow to send sample request
Fill The Form For Sample Request
Full Name :*
Bussiness Email: *
Email: *
Country :*
Contact No.*
Alternate No.
Note.:*Kindly provide us with your company id and get the sample reports at the earliest.
There is no Reviews available

Delivery Details

PDF FORMAT REPORTS will be delivered by email within 12 to 24 hours after placing the order (Mon-Fri IST)

CHOOSE FORMAT

  • PDF    USD 2995
  • Site Licence    USD 5990
  • Enterprise Wide Licence    USD 8985
$ 2995

Reports Details

Published Date : Feb 2018
No. of Pages :449
Country :Global
Category :Pharmaceuticals and Healthcare
Publisher :MarketLine
Report Delivery By :Email
Report Delivery Time :12 to 24 hours after placing the order.

Customized Research

If you do not find this specific report suitable to your exact needs then you can also opt for customized research report that will befit all your expectation. To specify your requirements CLICK HERE

 

We Accept

  • fb
  • twitter
  • pinterest
  • linckedin
  • rss
  • youtube